Longboard Pharmaceuticals Inc reports results for the quarter ended in September - Earnings Summary

Longboard Pharmaceuticals

03/11/2022 13:57

* Longboard Pharmaceuticals Inc  LBPH.OQ  reported a
quarterly
adjusted loss of 68 cents​​ per share for the quarter ended in
September. The mean expectation of five analysts for the quarter
was for a loss of 64 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * Longboard Pharmaceuticals Inc's reported EPS for the
quarter was
a loss of 68 cents​.
    * The mean earnings estimate of analysts had fallen by
about 3.8%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Longboard Pharmaceuticals Inc shares had risen by 1.6%
this
quarter and lost 22.5% so far this year.
    * The company reported a quarterly loss of $11.6 million.
    * Wall Street's median 12-month price target for Longboard
Pharmaceuticals Inc is $19.50 
    * The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 6 "strong buy" or
"buy," no "hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
3 at 01:56 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.64          -0.68          Missed
 Jun. 30 2022      -0.57          -0.67          Missed
 Mar. 31 2022      -0.55          -0.56          Missed
 Dec. 31 2021      -0.43          -0.52          Missed